ARCH Venture Partners X Overage, L.P.
Reporting owner on Forms 3, 4 and 5, CIK 1768905.
- In the filer group ARCH Venture Partners XII, LLC
ARCH Venture Partners X Overage, L.P. reported on 1 issuer in 4 filings, the latest a 13D/A filed 2026-11-13.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Aspen Neuroscience, Inc. CIK 2124080 | 10% owner | 2 | 2026-11-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | P bought | +66,666 | $15 | 66,666 | Form 4 |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +187,182 | 253,848 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +298,258 | 552,106 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +286,304 | 838,410 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +295,490 | 1,133,900 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +259,948 | 1,393,848 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | P bought | +66,667 | $15 | 66,667 | Form 4 |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +298,258 | 364,925 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +286,304 | 651,229 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +295,490 | 946,719 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | C converted | +214,355 | 1,161,074 | Form 4 | |
| Aspen Neuroscience, Inc. Common Stock | 2026-11-02 | P bought | +1,200,000 | $15 | 1,200,000 | Form 4 |
| Aspen Neuroscience, Inc. Series Seed Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -187,182 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -298,258 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -298,258 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -286,304 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -286,304 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series B Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -295,490 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series B Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -295,490 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -259,948 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative | 2026-11-02 | C converted | -214,355 | 0 | Form 4 | |
| Aspen Neuroscience, Inc. Series Seed Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Series B Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Series B Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13D/A 0001193125-26-460600 | PRME | 2026-11-13 | ||
| 13D 0001193125-26-454047 | ASPE | 2026-11-09 | ||
| Form 4 0001193125-26-444147 | Aspen Neuroscience, Inc. | 2026-11-02 | ||
| Form 3 0001193125-26-439136 | Aspen Neuroscience, Inc. | 2026-10-29 |